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ABSTRACT
Diabetes mellitus (DM) is the most common endocrine metabolic disorder, characterized by hyperglycemia. The cause of this hyperglycemia is either 
insufficient or inefficient insulin that leads to the imbalance in the metabolism of not only carbohydrates but also protein and lipids. DM is associated 
with various kinds of abnormalities which affects almost all the parts of the body including eye, kidney, brain, foot, etc. Hyperglycemia is not the only 
reason which gives DM a tag of most apocalyptic disease; it is the complications that arise from the higher concentration of glucose or metabolites 
come from its variant metabolic pathways. DM causes both microvascular and macrovascular complications. Microvascular complications, caused 
by the damage of small blood vessels, include nephropathy (kidney disease), retinopathy (eye damage) and neuropathy (nerve damage), whereas 
macrovascular complication, caused by the damage of large blood vessels, includes blood vessels arteries and veins. There are six metabolic pathways 
are there which normally leads to these complications. These pathways are sorbitol pathway, advanced glycation pathway, Hexosamine pathway, 
protein kinase C pathway, ketoaldehyde pathway, and oxidative stress.
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INTRODUCTION
The disease, diabetes mellitus (DM), was known to humankind from the 
very beginning. The ancient Hindu Vedas and other old Indian Sanskrit 
texts explained in the 6th century AD the sweetness of urine. The Hindu 
physician Charak (200 AD), mentioned most of the clinical features of this 
disease in Charak Samhita as Madhumeha. In this book, he also described 
the relationship between obesity and diabetes, the tendency of the disease 
to be transmitted from generation to generation. Sushruta (500 AD) 
gave the description of the disease as Madhumeya, Ikhumeha, or honey 
urine, as the urine of the patients tasted sweet. He also described and 
mentioned two varieties of Madhumeya, of which one group of patients 
were lean and thin and wasted to death and another group of patients 
were obese with complications and died a slow death [1,2].
DM is not a single disease; rather it is a group of abnormalities 
characterized by abnormally hyperglycemia resulting from insufficient 
or inefficient insulin or both [3]. An increase in blood glucose because 
of food intake, insulin secretion from the pancreatic beta cells has been 
triggered. Insulin works on hepatocytes to increase the mobilization 
of blood glucose and on muscle and fat cells to use blood glucose, 
causing a reduction in blood glucose level to the normal level. DM 
causes secondary complications such as blindness, kidney damage, 
cardiovascular disease, and lower-limb amputations and increases the 
mortality and morbidity. Diabetics can decrease the prevalence of these 
complications by managing their blood glucose, blood pressure, and 
blood lipid level within the normal range [4,5].
BIOCHEMISTRY OF DIABETES
DM is an endocrine multifactorial metabolic disorder which is 
characterized by two major defects: Decrease in insulin production 
by the pancreatic beta cells and resistance to the action of insulin at 
different target tissues (muscle, liver, and adipose), which ultimately 
leads to an impaired glucose uptake. The exact molecular mechanism 
of insulin resistance is not well-known precisely, but defects in post-
insulin receptor intracellular signaling pathways are believed to play an 
important role here [6,7]. There are a number of factors responsible for 
insulin resistance, which is usually present before the onset of diabetes 
such as genetics, age, obesity, and hyperglycemia itself [8]. Most 
important contributor for the fasting hyperglycemia during diabetes is 
the unregulated hepatic glucose production [9].
The increased lipolysis by insulin resistant adipose cells and the 
subsequent increased circulating free fatty acids contribute to the 
secondary complications of DM by impairing the b-cells function, glucose 
uptake in skeletal muscles, and increasing gluconeogenesis in the liver. 
Adipose tissues have been emerged as an important endocrine gland which 
produces a number of hormones collectively known as adipocytokines 
or “adipokines.” Hormones produced by adipocytes regulate insulin 
sensitivity such as resistin and adiponectin, food uptake like leptin, 
inflammation such as tumor necrosis factor-α (TNF-α), interleukin-6 
,and factors affecting blood coagulation such as plasminogen activator 
inhibitor-1 (PAI-1) [10]. As diabetes progresses, insulin production 
and secretion slow down which results in progressive hyperglycemia. 
Hyperglycemia itself aggravates insulin resistance and decreases insulin 
secretion, which is known as called glucotoxicity. The main reason and the 
mechanism of progressive failure of pancreatic β-cell is not completely 
known, but a number of factors involved in this pathophysiology of 
diabetes, which include genetic determinants, glucotoxicity chronic 
inflammation, and the harmful effect of elevated levels of free fatty 
acids on the functioning of β-cell, called as lipotoxicity [10,11]. Multiple 
organs are affected in this case namely muscle, liver, adipose tissues, and 
pancreas, generate the pathogenic condition that causes diabetes.
Diabetes is undoubtedly one of the fastest growing non-communicable 
health problems in the current century and has emerged as a major 
healthcare problem in India. According to Diabetes Atlas published by 
the International Diabetes Federation (IDF), there are an estimated 
382 million persons with diabetes in the world in 2013, and this number 
is predicted to rise to almost 592 million people by 2035 with 55% 
increase in the cases [12]. The major part of diabetic people is between 
the age group of 40 and 59, and some 80% of this population live in low-
income and middle-income countries (IDF Atlas 2014). All the types of 
diabetes are on the increase; especially type 2 which might increase by 
55% by 2035. Globally, the number of diabetics increase continuously 
due to increment in aging population, flawless urbanization, less 
physical inactivity, the high prevalence of obesity, and sedentary 
lifestyle [13,14]. In the case of developing countries also, urbanization 
was treated as a measure for the increased risk of DM, which is also 
associated with some or more other reasons such as altered diet, 
obesity, decreased physical activity, and increased stress [12]. The 
global figure on the prevalence of diabetes in the 20-79 age groups is 
listed in Table 1.
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The transition from a traditional to modern lifestyle, consumption of 
fat-rich diet and high calories food and an increased level of mental 
stress has compounded the problem up to the next level. In addition 
to genetic factors, obesity due to improved economic status is a major 
factor in this epidemic. In many parts of the developing world, low birth 
weight and maternal malnutrition during pregnancy may also play a 
leading role in insulin resistance [12].
SECONDARY COMPLICATION CAUSED IN DIABETES
All different types of diabetes are characterized by fasting and post-
prandial hyperglycemia and relatively insulin insufficiency. Diabetic 
peoples are at high risk for developing various kinds of disabilities 
and life-threatening complications. In the case of unmanaged DM, the 
hyperglycemia causes cause chronic microvascular and macrovascular 
complications such as weight gain, neuropathy, nephropathy, 
retinopathy, and arteriosclerosis [15,16]. It is also associated with 
the accelerated such atherosclerotic macrovascular disease affecting 
arteries which carries blood to the heart, brain, and lower extremities. 
In the early stages, intracellular hyperglycemia causes abnormalities 
in blood flow and increased vascular permeability. In the case of 
all high-income countries, diabetes is a leading cause of blindness, 
renal failure, atherosclerotic diseases, and amputations, especially 
in lower-limbs. Among all these complications atherosclerosis is the 
most important cause of mortality and morbidity in the peoples with 
diabetes.
There are a number of biochemical metabolic pathways and various 
mechanisms of action for glucose toxicity have been reported by a 
different group of scientists. These pathways include polyol pathway, 
hexosamine pathway, methylglyoxal pathway, glucose autoxidation, 
protein kinase C (PKC) activation, methylglyoxal formation and 
glycation, and oxidative phosphorylation (OXPHOS) [17] (Fig. 1).
There are many potential mechanisms whereby excess glucose 
metabolites traveling along these pathways might cause damage to 
b-cell. All such pathways have in common feature of the formation of 
reactive oxygen species (ROS) higher rate with growing time span [18] 
cause chronic oxidative stress, which promotes the development of 
microvascular and cardiovascular diseases [15,19,20]. This in turn 
results in expression of defective insulin gene and decreased insulin 
secretion as well as increased pancreatic beta cell apoptosis [21-25].
Houstis et al. have shown that the treatment of 3T3-L1 adipocytes 
with TNF-α or dexamethasone increases the ROS levels and 
results in decreased insulin secretion. Antioxidant molecules or 
transgene encoding ROS scavenging enzymes ameliorate the insulin 
resistance caused by TNF-α or dexamethasone-treated 3T3-L1 
adipocytes [26].
In physiologic physiological concentrations, endogenous ROS help to 
maintain homeostasis. However, when these free radicals accumulate 
in higher concentration and for longer periods of time, they cause 
chronic oxidative damage and other adverse effects on cells as well as 
biomolecules. This is particularly important and problematic for the 
pancreatic islet cells, which are among those tissues which contains 
the lowest levels of intrinsic antioxidant defenses. As minimum as six 
different glucose metabolic pathways are emphasized in the reports 
as chief contributors of ROS leading to the various effects and they are 
listed below (Fig. 1).
Polyol pathway
It is also known as sorbitol pathway since the intermediate of 
this pathway is sorbitol. It is implicated in diabetic complications, 
especially in the microvascular damage to the retina, kidney, and 
nerves [27]. Cells utilize glucose for energy production, but the unused 
glucose enters the polyol pathway and gets converted to the sorbitol 
due to the action of the enzyme, aldose reductase, and the cofactor 
nicotinamide adenine dinucleotide phosphate (NADPH) (Fig. 2). 
Sorbitol cannot cross cell membranes, and when it accumulates, it 
produces osmotic stress on cells by drawing water into the insulin-
independent tissues [28].
This step consumes NADPH, which is required for the regeneration of 
reduced glutathione (GSH). This could induce intracellular oxidative 
stress [17]. In the next step of the reaction, sorbitol dehydrogenase 
oxidizes sorbitol to fructose, which also produces NADH from NAD+. 
Hexokinase can return the molecule to the glycolysis pathway by 
phosphorylating fructose to form fructose-6-phosphate. However, if the 
blood glucose is more than that can be handled in the glycolysis pathway, 
the mass balance ultimately favors the production of sorbitol [29]. 
This reaction increases cytosolic NADH: NAD+ ratio, inhibiting the 
Table 1: Estimated number of people with diabetes (age group 
of 20-79 years) in 2014 and 2035
Ranking 2014 2035
Country People with 
diabetes 
(millions)
Country People with 
diabetes 
(millions)
1 China 103.2 China 109.7
2 India 77.4 India 104.2
3 USA 22.6 USA 25.7
4 Indonesia 15.6 Indonesia 21.2




7 Pakistan 10.2 Nigeria 14.9
8 Japan 9.4 Bangladesh 13.3
9 Bangladesh 9.4 Mexico 10.3
10 Nigeria 8.0 Russian 
Federation
9.6
Fig. 1: Potential mechanisms by which hyperglycemia and its 
immediate biochemical sequelae lead to the formation of reactive 
oxygen species. Under pathologic conditions of hyperglycemia, 
excessive glucose levels can swamp the glycolytic process and 
inhibit glyceraldehyde catabolism, which cause glucose, fructose-
1,6-bisphosphate, and glyceraldehyde-3-P to be shunted to other 
pathways: (1) Sorbitol metabolism; (2) hexosamine metabolism; 
(3) PKC activation; (4) enolization and α-ketoaldehyde formation; 
(5) oxidative phosphorylation; and (6) dicarbonyl formation and 
glycation (Robertson, 2004)
Fig. 2: Polyol pathway-induced oxidative stress
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enzyme glyceraldehyde-3-phosphate dehydrogenase, and increases 
the concentration of triose phosphate. This increases the formation of 
methylglyoxal, a precursor of advanced glycation end products (AGEs) 
and diacylglycerol (DAG), thus activating PKC [17].
Hexosamine pathway
The excess intracellular glucose is shunted to the hexosamine pathway 
in many tissues during diabetes. This could contribute to oxidative 
stress because of the inhibition of the pentose shunt pathway, thereby 
diminishing the production of the cellular antioxidant leading to the 
reduction in reduced GSH [30]. In the hexosamine pathway, fructose-
6-phosphate is converted to N-acetylglucosamine-6-phosphate 
(GlcNAc) by the rate limiting enzyme glutamine: Fructose-6-
phosphate amidotransferase (GFAT). It is then converted to uridine 
diphosphate N-acetylglucosamine (GlcNAc). This is a substrate for 
O-linked glycosylation of the proteins, which is catalyzed by O-GlcNAc 
transferase (Fig. 3) [17]. There are reports that the increased activity 
of the hexosamine pathway may contribute to glucose-induced insulin 
resistance [31].
PKC pathway
PKC is a family of enzymes that are involved in controlling the functions 
of other proteins through the phosphorylation of hydroxyl groups 
in serine and threonine amino acid residues in the proteins. PKC 
enzymes in turn, are activated due to increasing the concentration of 
diacylglycerol or Ca2+ [32]. Hence, these enzymes play important roles 
in several signal transduction cascades [33]. There are about eleven 
isoforms of PKC, nine of which are activated by the DAG. Intracellular 
hyperglycemia increases the amount of DAG in diabetic animals [33]. 
Activated PKC has a number of pathogenic consequences including 
affecting the expression of endothelial nitric oxide synthase [34], 
endothelin-1 [35], and vascular endothelial growth factor [36]. It also 
transforms the growth factor-b and PAI-1 [37], by activating nuclear 
factor kappa B (NF-kB) and NAD (P) H oxidases [38]. The abnormalities 
caused by these actions are summarized in Fig. 4.
Autoxidation of glyceraldehyde
In addition to the classical pathway of glucose metabolism, there is a 
less familiar alternative pathway for the autoxidation of glyceraldehyde 
(Fig. 1, pathway 4). The autoxidation of α-hydroxyaldehydes generates 
hydrogen peroxide (H2O2) and α-ketoaldehydes [39]. In the presence of 
redox active metals, H2O2 can form the highly toxic hydroxyl radicals. 
This pathway forms two potentially toxic substances, α-ketoaldehydes, 
which contribute to glycosylation-related protein chromophore 
development, and the hydroxyl radical, an ROS that can cause mutagenic 
alterations in the DNA. Although glyceraldehyde is thought of as an 
insulin secretagogue, when present in excess, it may also inhibit insulin 
secretion [40].
Long-term exposure to high glucose concentrations decreases 
glyceraldehyde-phosphate dehydrogenase (GAPDH) activity in 
islets [41], which favors the accumulation of an excess of glyceraldehyde. 
Exposure of endothelial cells to high glucose concentration causes 
inhibition of GAPDH [42], through the mechanism of ROS-activated 
poly(ADP-ribosyl)ation of GAPDH by the poly(ADP-ribose) polymerase. 
This in turn is associated with intracellular AGE formation and 
activation of PKC, the hexosamine pathway, and NF-κB, a protein 
complex that controls transcription [18].
OXPHOS
Mitochondria are the major source of energy generation in the cells. 
38% fewer mitochondria have been reported in the muscles of insulin 
resistant individuals when compared to control [43]. High glucose 
concentration increases the overproduction of electron donors by 
the tricarboxylic acid cycle, which in turn increases the production of 
mitochondrial superoxide [44] (Fig. 1, pathway 5). Lipotoxicity and 
glucotoxicity in obese and T2DM subjects induce the overexpression 
of β-cell uncoupling protein 2, which increases the proton leakage 
across the mitochondrial inner membrane and decreases ATP 
synthesis leading to insufficient secretion of insulin. Insulin resistance 
in the target tissues has been related to decreasing in mitochondrial 
content, reduced fatty acid oxidation, defective OXPHOS, and poor ATP 
production [45]. The decreased fatty acid oxidation, caused either by 
the reduced number of mitochondria or mitochondrial dysfunction, 
increases the levels of fatty acyl-CoA and DAG. These molecules activate 
PKC and finally inhibit the recruitment of GLUT4 to the membrane and 
insulin-mediated glucose uptake [46].
Formation of AGE
AGEs are a heterogeneous group of molecules formed from the non-
enzymatic reaction of reducing sugars with free amino groups in 
proteins, lipids, and nucleic acids (Fig. 1, pathway 6). They are formed at 
a constant and slow rate in the normal body, starting in early embryonic 
development, and accumulating with time. However, their accumulation 
Fig. 3: Hexosamine pathway for biosynthesis of uridine 
diphosphate N-acetylglucosamine
Fig. 4: Abnormalities arising out of the activation of protein 
kinase C caused due to hyperglycemia`
Table 2: AGE-mediated effects in various macro and 
microvascular beds
Alter cell viability ↑↓ Vascular smooth muscle growth
↑↓ Vascular endothelial cell viability
Thrombosis ↑ Adhesion molecule expression
↑ Activity of transcription factor NF‑κB
↑ Tissue factor (Procoagulants)
↓ Thrombomodulin (Anticoagulants)
↑ Atherogenesis
Blood rheology ↑ Pro‑inflammatory cytokine release
Vasopermeability ↑ Endothelial cell permeability
↓ Basement membrane charge selectivity




ECM dysregulation ↑ Mesangial cell matrix production
↓ Skin elasticity
↑  Thickness, cross‑linking and resistance 
to degradation
↑ Vascular wall stiffness
ECM: Extracellular matrix, eNOS: Endothelial NO synthase, NO: Nitric oxide, 
NF‑κB: Nuclear factor kappa B, AGE: Advanced glycation end products
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is markedly accelerated in diabetes because of the increased availability 
of glucose [47]. The production of AGEs can cause damage to target 
tissues by three general mechanisms namely [48,49].
• Modification of intracellular protein by AGEs
• Modification of extracellular matrix protein and components
• Modification of plasma protein by AGEs.
Diabetes-mediated of AGEs formation and accumulation during the DM 
have been widely implicated in all macrovascular and microvascular 
complications [50] (Table 2).
The reactivity of AGEs may be less or more than the initial sugars from 
which they are formed. They are absorbed by the body during digestion 
with about 30% efficiency. Many cells in the body (such as endothelial 
cells, smooth muscle or cells of the immune system) from tissues such as 
lung, liver, kidney, or peripheral blood bear the receptor for AGEs. These 
bind to the AGEs and contribute to age and diabetes-related chronic 
inflammatory diseases including atherosclerosis, asthma, arthritis, 
myocardial infarction, nephropathy, retinopathy, or neuropathy [47].
Almost every organ in the human body is affected after prolonged 
hyperglycemia as listed in Table 3.
CONCLUSIONS
Diabetes is a chronic disorder causing due to the abnormality in the 
insulin synthesis or its action or both together. The most serious 
complication caused in the case of DM is their side effect and secondary 
complications which arise due to the assemblage of glucose. This 
accumulated glucose is harbored into different metabolic pathways 
which lead to the production of various compounds and metabolites 
and also generated free radicals, which damage the systemic organs 
and organelles. Medicines to control these secondary complications 
are unavailable in today’s market. DM cannot be cured only it will 
be managed through proper management of food habit, physical 
exercises, and drugs. Long-term glucose homeostasis is required to 
reduce diabetes-related secondary complications. Glycemic control 
has a positive effect on both macrovascular and microvascular 
complications of DM for management and preventing the new onset of 
the complication and decelerating the progression these complications.
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